These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22814877)

  • 1. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?
    Leslie JL; Cohen SH; Solnick JV; Polage CR
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3295-9. PubMed ID: 22814877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay.
    Dionne LL; Raymond F; Corbeil J; Longtin J; Gervais P; Longtin Y
    J Clin Microbiol; 2013 Nov; 51(11):3624-30. PubMed ID: 23966497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.
    Landry ML; Ferguson D; Topal J
    J Clin Microbiol; 2014 Jan; 52(1):275-80. PubMed ID: 24226924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
    Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
    J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.
    LaSala PR; Ekhmimi T; Hill AK; Farooqi I; Perrotta PL
    J Clin Microbiol; 2013 Jan; 51(1):311-3. PubMed ID: 23135940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.
    Turgeon DK; Novicki TJ; Quick J; Carlson L; Miller P; Ulness B; Cent A; Ashley R; Larson A; Coyle M; Limaye AP; Cookson BT; Fritsche TR
    J Clin Microbiol; 2003 Feb; 41(2):667-70. PubMed ID: 12574264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
    Kvach EJ; Ferguson D; Riska PF; Landry ML
    J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
    Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
    J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.
    Merz CS; Kramer C; Forman M; Gluck L; Mills K; Senft K; Steiman I; Wallace N; Charache P
    J Clin Microbiol; 1994 May; 32(5):1142-7. PubMed ID: 8051237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the diagnostic performance of the xpert Clostridium difficile assay and its comparison with the toxin A/B enzyme-linked fluorescent assay and in-house real-time PCR assay used for the detection of toxigenic C. difficile.
    Whang DH; Joo SY
    J Clin Lab Anal; 2014 Mar; 28(2):124-9. PubMed ID: 24395702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.
    Savolainen R; Koskinen JM; Mentula S; Koskinen JO; Kaukoranta SS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31941691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
    Larson AM; Fung AM; Fang FC
    J Clin Microbiol; 2010 Jan; 48(1):124-30. PubMed ID: 19923482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort study.
    Leis JA; Gold WL; Ng J; Hirji Z; Pillai DR; Broukhanski G; Raggiunti P; Hota S; McGeer A; Poutanen SM
    BMC Infect Dis; 2013 Jul; 13():324. PubMed ID: 23865713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
    Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
    J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.